Abstract
The polo-like kinase (Plk) family is comprised of five different members (Plk1–5), each with their own distinct functions. Plk family members participate in pivotal cell division processes as well as in non-mitotic roles. Importantly, Plk expression has been correlated with various disease states, including cancer. Multiples therapies, which primarily target Plk1, are currently being investigated alone or in combination with other agents for clinical use in different cancers. As the role of Plks in disease progression becomes more prominent, it is important to outline their functions as cell cycle regulators and more. This review summarizes the structure and both mitotic and non-mitotic functions of each of the five Plk family members, sequentially. Additionally, the proposed mechanisms for how Plks contribute to tumorigenesis and the therapeutics currently under investigation are outlined.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 254-263 |
| Number of pages | 10 |
| Journal | Molecular Carcinogenesis |
| Volume | 61 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Molecular Biology
- Cancer Research
Fingerprint
Dive into the research topics of 'A review of Plks: Thinking outside the (polo) box'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver